 | • レポートコード：MRC2303G024 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の市場調査書によると、世界の膀胱スキャナー市場規模が、2021年には134.43百万ドルに及び、予測期間中、CAGR 5.55％で増加すると推測されています。本書では、膀胱スキャナーの世界市場について広く調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別（手動、自動）分析、エンドユーザー別（病院、診断センター、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などの項目について記載しています。並びに、本書に記載されている企業情報には、Becton, Dickinson and Company (C. R. Bard Inc.)、Caresono、GE Healthcare Inc、Mcube Technology Co. Ltd、Echo-Son SA、Patricia Industries (LABORIE)などが含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の膀胱スキャナー市場規模：製品別 - 据え置き型膀胱スキャナーの市場規模 - 移動型膀胱スキャナーの市場規模 - 手持ち型膀胱スキャナーの市場規模 ・世界の膀胱スキャナー市場規模：エンドユーザー別 - 病院における市場規模 - 診断センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の膀胱スキャナー市場規模：地域別 - 北米の膀胱スキャナー市場規模 アメリカの膀胱スキャナー市場規模 カナダの膀胱スキャナー市場規模 メキシコの膀胱スキャナー市場規模 … - ヨーロッパの膀胱スキャナー市場規模 ドイツの膀胱スキャナー市場規模 イギリスの膀胱スキャナー市場規模 フランスの膀胱スキャナー市場規模 … - アジア太平洋の膀胱スキャナー市場規模 中国の膀胱スキャナー市場規模 日本の膀胱スキャナー市場規模 インドの膀胱スキャナー市場規模 … - 南米/中東の膀胱スキャナー市場規模 ブラジルの膀胱スキャナー市場規模 アルゼンチンの膀胱スキャナー市場規模 サウジアラビアの膀胱スキャナー市場規模 … ・競争状況 ・市場機会・将来動向 |
The bladder scanners market is estimated to be USD 134.43 million in 2021, registering a CAGR of 5.55% during the forecast period.
The COVID-19 pandemic affected the global economy and the bladder scanner market. Various public health organizations issued guidelines for the diagnosis of bladder cancer during the pandemic. For instance, according to the study published in the National Library of Medicine in January 2021, the outpatient visit of urology patients was minimized, and only patients with progressively deteriorating disease conditions or organ or life-threatening conditions were recommended to visit the urology clinic. The urology procedures other than emergency cases were deferred.
In addition, patients with outpatient urological procedures such as prostate biopsy follow-up cystoscopy, ureteral stents, nephrostomy tube replacement, and intravesical therapy for low-risk nonmusical invasive bladder cancer were deferred from visiting the clinics. However, the article titled ‘Study explores OAB symptoms emerging in COVID-19 patients’ published in September 2021 reported that patients with COVID-19 were experiencing new onset and worsening overactive bladder (OAB) symptoms resulting from cystitis. It is also known as COVID-19–associated Cystitis (CAC), which includes increased urinary urgency, frequency, nocturia, and pain. Such new symptoms associated with COVID-19 propel the growth of the market. Similarly, initiatives by the key market players during the pandemic are expected to increase the market growth. For instance, in January 2022, Laborie Medical Technologies Inc. announced the acquisition of an exclusive license to the Optimum Urethral Drug-Coated Balloon (DCB). Thus, the market is expected to grow during the forecast period.
A bladder scanner is a non-invasive ultrasound device or a tool that provides a virtual two or three-dimensional (3D) or (2D) image of the bladder and the volume of urine retained within the bladder for diagnosing, managing, and treating urinary outflow dysfunction. The increasing prevalence of urological diseases is driving the growth of the bladder scanner market.
The growing burden of cancer related to the urinary tract creates the need for diagnostics and scanning devices and thus propels the growth of the market. For instance, the Global Cancer Observatory Statistics 2021 reported that bladder cancer and prostate cancer are among the top 10 high-incidence cancers globally. The same source also reported that in 2021, the estimated number of new cases of bladder cancer was 573,278, and that of prostate cancer was 1,414,259 cases among both sexes in the year 2020. Such a high incidence of cancer worldwide is propelling the market over time.
Furthermore, the increasing accessibility to technologically advanced scanners also propels the market’s growth. For instance, in March 2021, Lingen Davies Cancer Fund funded a new bladder scanner for the radiotherapy department at Royal Shrewsbury Hospital. The new bladder scanner is expected to allow a more accurate reading. It is expected to prevent a further CT Scan and therefore increase capacity in the department allowing patients with bladder, prostate, gynecological, or colorectal tumors to access this enhanced scanning equipment.
Moreover, in September 2021, Lilium Otsuka Co. Ltd, a subsidiary of Otsuka Pharmaceutical Factory Inc., launched Lilium-SPOT2, an improved version of Lilium-SPOT, a device for assisting urination timing prediction, as a healthcare appliance (non-medical device) that allows users to check the amount of urine in the bladder easily. The users can check the level of urine accumulation on a scale display by applying ultrasonic waves to the position of the bladder.
Additionally, the acquisition among the market players for the advanced technology for developing the product is also boosting the market’s growth. For instance, in April 2020, Essity acquired novioscan. The company develops a wearable ultrasound technology that monitors the bladder and enables continence control. Such an acquisition may also drive the growth of the market.
Thus, the high burden of urological conditions and technological advancement in scanners propel the market’s growth over the forecast period.
Bladder Scanners Market Trends
Portable Bladder Scanners Segment is Expected to Hold a Significant Market Share
Portable bladder scanners are ultrasound devices that use automated technology to register bladder volume digitally, including post-void residual (PVR) volume, and provide three-dimensional images of the bladder.
The major advantage of the portable ultrasound bladder scanner is to be a user-friendly diagnostic procedure with high-end accuracy. Another main benefit of a portable bladder ultrasound scanner is its portability, reliability, cost-effectiveness, and non-invasiveness.
The increasing prevalence of urological diseases and the rising preference for portable bladder scanner use are the key factors for the growth of the bladder scanner market. According to a research study published in BMC Geriatrics Journal in March 2021, the study results found that the highest prevalence of urinary incontinence was reported to be 45.1% in older women in Asia. Healthcare professionals (primarily nurses) use the device to measure postvoid residual (PVR) urine volume and prevent unnecessary catheterization, and these products may improve the diagnosis and differentiation of urological problems, which helps in the management and treatment of urological diseases, including the establishment of voiding schedules, study of bladder biofeedback, fewer urinary tract infections (UTIs), and monitoring of potential urinary incontinence after surgery or trauma.
Therefore, the increasing prevalence of urological diseases and the rising preference for portable bladder scanners are the key factors for the growth of the bladder scanner market.
North America is Expected to Dominate the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the bladder scanner market globally due to the rising prevalence of urological diseases and high healthcare expenditure. New product approvals, the growing prevalence of urological disorders, increasing diagnostic procedures, and increasing utilization of mobile portable ultrasound devices in clinics and hospitals contribute to the growth of the bladder scanners market.
According to the National Institutes of Health data updated in September 2021, chronic kidney disease (CKD) affects nearly one-seventh of all adults in the United States (i.e., 37 million people). The risk of CKD is much higher for Americans with diabetes or high blood pressure, the two most frequent causes of kidney disease. Kidney disease affects nearly one-third of diabetics and one-fifth of those with high blood pressure. Heart disease and a family history of renal failure are two more risk factors for kidney disease.
Additionally, as per the Canadian Institute for Health Information and the Canadian Patient Safety Institute, data updated March 2021, Urinary tract infections (UTIs) are the fifth most common type of healthcare-associated infection, with an estimated 62,700 UTIs in acute care hospitals (US) every year. UTIs account for more than 9.5% of infections reported by acute care hospitals. Hence, increasing chronic diseases led to an increased demand for bladder scanners, which increased the demand for bladder scanners in the region.
Adopting artificial intelligence in the devices helps in better workflow, accuracy, detection, and diagnosis of the disease. The launch of technically advanced products by market players is also augmenting the growth of the market studied. For instance, in June 2021, Verathon released the Bladderscan i10. It is a next-generation bladder volume measuring technology that may empower users with new capabilities that enhance leadership in ease of use and dependability. Additionally, the product safeguards clinical confidence through Imagesense, Verathon’s proprietary artificial intelligence deep learning technology.
Hence, due to the aforementioned factors, the bladder scanners market is anticipated to propel over the analysis period in North America.
Bladder Scanners Market Competitor Analysis
The bladder scanner market is moderately competitive and consists of several major players. In terms of market share, a few major players dominate the market. Market participants are adopting numerous strategies to sustain market competition, including acquisitions and collaborations. Some market players are GE Healthcare Inc., Mcube Technology Co. Ltd, Echo-Son SA, Patricia Industries (LABORIE), Roper Technologies Inc., SRS Medical Systems Inc., and Vitacon, among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Urology Related Disorders
4.2.2 Technological Advancements in Bladder Scanner
4.3 Market Restraints
4.3.1 Stringent Regulatory Reforms
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Product
5.1.1 Bench Top Bladder Scanners
5.1.2 Portable Bladder Scanners
5.1.3 Handheld Bladder Scanners
5.2 By End User
5.2.1 Hospitals
5.2.2 Diagnostic Centers
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company (C. R. Bard Inc.)
6.1.2 Caresono
6.1.3 GE Healthcare Inc
6.1.4 Mcube Technology Co. Ltd
6.1.5 Echo-Son SA
6.1.6 Patricia Industries (LABORIE)
6.1.7 Roper Technologies Inc.
6.1.8 SRS Medical Systems Inc.
6.1.9 Vitacon
7 MARKET OPPORTUNITIES AND FUTURE TRENDS